• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·FITX
Share

Creative Edge Nutrition, Inc. Stocks

$ 0Last Updated 18.09.2026

Issuer Rating

2/7
Performance

Average

Risk

Critical

Recommendation

Sell

Market Cap

$ 47480

$ 0
Key Takeaways

Risk factor

Critical default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Creative Edge Nutrition, Inc. develops and sells a portfolio of health–oriented nutrition products. The company offers products in the categories of weight loss, metabolic enhancement, recovery/well-being, muscle enhancement and stimulation, and natural line. Its products include MetaBolic Xtreme, a product for weight loss; Hyper-Infusion, a pre-workout powder to enhance endurance and strength; Alpha-Drive, a product for post cycle therapy; Amino Plex, an intra-workout recovery catalyst; Chia Plex, a product for health and well being; and Hemp Nutra Tea and Nutra Coffee additives. The company was formerly known as Laufer Bridge Enterprises Inc. and changed its name to Creative Edge Nutrition, Inc. in April 2012. Creative Edge Nutrition, Inc. is based in Madison Heights, Michigan.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is trading at neutral levels on P

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

22.09.2026 04:06

FT: Citi, Deutsche, and other banks processed $7 billion in Russian payments in defiance of sanctions

22.09.2026 01:05

The Nasdaq set a new record for the first time since June, while the S&P 500 had its best day since August

22.09.2026 00:41

The ECB has launched the first digital euro settlements in the interbank market

21.09.2026 23:48

Meta shares are having their best month in 13 years, with the price at its highest level since October. Is it too late to buy?

21.09.2026 23:31

A $30 Trillion Market and the Risk of an Apocalypse: How Much Could Anthropic Be Worth? — An FT Analysis

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026